Quester Capital
30
8M
20
0.81
7
0.33
10
- Stages of investment
- Areas of investment
Summary
In 1984 was created Quester Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Kuala Lumpur. The fund was located in Asia if to be more exact in Malaysia.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Quester Capital, startups are often financed by The Cambridge Gateway Fund, FNI Venture Capital, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are SPARK VCT, Nesta Ventures, Top Technology Ventures. In the next rounds fund is usually obtained by Spark Ventures, SPARK VCT, Wellington Partners.
Among the most popular portfolio startups of the fund, we may highlight Workshare, Critical Pharmaceuticals, UniServity. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has exact preference in some founders of portfolio startups. In case when startup counts 2 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Software, Database.
The top amount of exits for fund were in 2011. The top activity for fund was in 2007. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. This Quester Capital works on 1 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 30
- Lead investments
- 7
- Exits
- 10
- Rounds per year
- 0.81
- Follow on index
- 0.33
- Investments by industry
- Software (14)
- Biotechnology (9)
- Enterprise Software (9)
- Health Care (7)
- Health Diagnostics (6) Show 33 more
- Investments by region
-
- United Kingdom (27)
- United States (3)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 30M
- Group Appearance index
- 0.87
- Avg. company exit year
- 13
- Avg. multiplicator
- 1.95
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Oxford Immunotec | 10 Aug 2005 | Biotechnology, Health Care, Health Diagnostics | Early Stage Venture | 9M | England, Vale of White Horse, United Kingdom |
Perpetuum | 22 Feb 2006 | Information Technology, Industrial, Wireless | Early Stage Venture | 3M | United Kingdom, England, Southampton |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.